GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Aspira Pathlab & Diagnostics Ltd (BOM:540788) » Definitions » Capital Expenditure

Aspira Pathlab & Diagnostics (BOM:540788) Capital Expenditure : ₹0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Aspira Pathlab & Diagnostics Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Aspira Pathlab & Diagnostics's cash flow for capital expenditures for the three months ended in Sep. 2024 was ₹0.0 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Sep. 2024 was ₹0.00 Mil.

Aspira Pathlab & Diagnostics Capital Expenditure Historical Data

The historical data trend for Aspira Pathlab & Diagnostics's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspira Pathlab & Diagnostics Capital Expenditure Chart

Aspira Pathlab & Diagnostics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.47 -2.96 -6.07 -1.36 -2.63

Aspira Pathlab & Diagnostics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Aspira Pathlab & Diagnostics Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspira Pathlab & Diagnostics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Aspira Pathlab & Diagnostics Ltd (BOM:540788) » Definitions » Capital Expenditure
Comparable Companies
BOM:526546 BOM:540729 BOM:539267 BOM:526301 BOM:542918 BOM:541299 BOM:526504 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN LH DGX WAT
Traded in Other Exchanges
N/A
Address
6 & 7, Bhaveshwar Arcade, Near Shreyas Junction LBS Marg, Behind Saraswat Bank, Ghatkopar (west), Mumbai, MH, IND, 400086
Website
https://www.aspiradiagnostics.com
Aspira Pathlab & Diagnostics Ltd is an India based company engaged in the business of running laboratories for carrying out Pathological investigations in various branches of Bio-chemistry, Hematology, Histopathology, Microbiology, Immuno-chemistry, Immunology, Virology, Cytology, other pathological and radiological investigations. Geographically, it operates only in India.

Aspira Pathlab & Diagnostics Headlines

No Headlines